The competitive NMDA antagonist CGP40.116 enhances L-DOPA response in MPTP-treated marmosets

Reversal of Experimental Parkinsonism by Lesions of the Subthalamic Nucleus

1990 • 1,875 citations

Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism

1987 • 420 citations

Excitatory amino acid binding sites in the basal ganglia of the rat: A quantitative autoradiographic study

1992 • 369 citations

Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders

1987 • 276 citations

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine‐depleted rats and MPTP‐treated monkeys

1991 • 258 citations

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1991 • 201 citations

CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐<scp>d</scp>‐aspartate receptor antagonists with oral activity

1990 • 186 citations

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

1991 • 135 citations

Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey

1989 • 76 citations

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

1990 • 63 citations

An receptor mediated excitatory postsynaptic potential evoked in subthalamic neurons in an in vitro slice preparation of the rat

1988 • 39 citations

Are N-methyl-d-aspartate (NMDA) and phencyclidine (PCP) receptors always functionally coupled to each other?

1990 • 10 citations